» Articles » PMID: 37533767

Applications of Multi-omics Analysis in Human Diseases

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2023 Aug 3
PMID 37533767
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-omics usually refers to the crossover application of multiple high-throughput screening technologies represented by genomics, transcriptomics, single-cell transcriptomics, proteomics and metabolomics, spatial transcriptomics, and so on, which play a great role in promoting the study of human diseases. Most of the current reviews focus on describing the development of multi-omics technologies, data integration, and application to a particular disease; however, few of them provide a comprehensive and systematic introduction of multi-omics. This review outlines the existing technical categories of multi-omics, cautions for experimental design, focuses on the integrated analysis methods of multi-omics, especially the approach of machine learning and deep learning in multi-omics data integration and the corresponding tools, and the application of multi-omics in medical researches (e.g., cancer, neurodegenerative diseases, aging, and drug target discovery) as well as the corresponding open-source analysis tools and databases, and finally, discusses the challenges and future directions of multi-omics integration and application in precision medicine. With the development of high-throughput technologies and data integration algorithms, as important directions of multi-omics for future disease research, single-cell multi-omics and spatial multi-omics also provided a detailed introduction. This review will provide important guidance for researchers, especially who are just entering into multi-omics medical research.

Citing Articles

Metabolically Healthy Obesity Is Characterized by a Distinct Proteome Signature.

Mir F, Abdesselem H, Cyprian F, Iskandarani A, Doudin A, Shraim M Int J Mol Sci. 2025; 26(5).

PMID: 40076884 PMC: 11901089. DOI: 10.3390/ijms26052262.


Temporal Transcriptomic Analysis of Periodontal Disease Progression and Its Molecular Links to Systemic Diseases.

Nantakeeratipat T, Fujihara C, Takedachi M Int J Mol Sci. 2025; 26(5).

PMID: 40076622 PMC: 11900451. DOI: 10.3390/ijms26051998.


Advancing Alzheimer's Therapy: Computational strategies and treatment innovations.

Paul J, Malik A, Azmal M, Gulzar T, Afghan M, Talukder O IBRO Neurosci Rep. 2025; 18:270-282.

PMID: 39995567 PMC: 11849200. DOI: 10.1016/j.ibneur.2025.02.002.


Phytoconstituents of Exert Benefits for ADHD Conditions by Targeting SLC6A4: Extraction, Spectroscopic Characterization, Phytochemical Screening, , and Computational Perspectives.

Mohan K, Ravichandran N, Rajendran H, Roshni J, Sivakumar M, Velayudam J ACS Omega. 2025; 10(5):4261-4275.

PMID: 39959106 PMC: 11822522. DOI: 10.1021/acsomega.4c05522.


Editorial: Advancements in proteomics and PTMomics: unveiling mechanistic insights and targeted therapies for metabolic diseases.

Chen X, Li Y, Braconi D Front Cell Dev Biol. 2025; 13:1556129.

PMID: 39925740 PMC: 11802801. DOI: 10.3389/fcell.2025.1556129.


References
1.
Wang T, Shao W, Huang Z, Tang H, Zhang J, Ding Z . MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun. 2021; 12(1):3445. PMC: 8187432. DOI: 10.1038/s41467-021-23774-w. View

2.
Chen C, Wang J, Pan D, Wang X, Xu Y, Yan J . Applications of multi-omics analysis in human diseases. MedComm (2020). 2023; 4(4):e315. PMC: 10390758. DOI: 10.1002/mco2.315. View

3.
McMahon C, Ferng T, Canaani J, Wang E, Morrissette J, Eastburn D . Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia. Cancer Discov. 2019; 9(8):1050-1063. DOI: 10.1158/2159-8290.CD-18-1453. View

4.
Meng C, Helm D, Frejno M, Kuster B . moCluster: Identifying Joint Patterns Across Multiple Omics Data Sets. J Proteome Res. 2015; 15(3):755-65. DOI: 10.1021/acs.jproteome.5b00824. View

5.
Karayel O, Virreira Winter S, Padmanabhan S, Kuras Y, Vu D, Tuncali I . Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease. Cell Rep Med. 2022; 3(6):100661. PMC: 9245058. DOI: 10.1016/j.xcrm.2022.100661. View